Woodcock's future retirement will mark new era for FDA's drug center

10/10/2013 | Reuters

Some drugmakers are worried that the pace of drug approvals could slow after Janet Woodcock retires as director of the FDA's Center for Drug Evaluation and Research, according to this article. Woodcock is at least a year away from leaving that role. FDA divestment rules and other obstacles can make it hard to find a successor, she said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ